Journal Title：Clinica Chimica Acta

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

國際臨床化學和實驗室醫(yī)學聯(lián)合會 (IFCC) 官方期刊

Clinica Chimica Acta 是一本高質量期刊，發(fā)表臨床化學和實驗室醫(yī)學領域的原創(chuàng)研究通訊，臨床化學和實驗室醫(yī)學定義為化學、生物化學、免疫化學、血液學生化方面、毒理學和分子生物學在體液和細胞中人類疾病研究中的診斷應用。

該期刊的目標是發(fā)表新穎的??信息，從而更好地了解人類疾病的生物機制、預防、診斷和患者管理。也歡迎具有應用臨床特征的報告。與正常代謝過程或正常細胞或體液成分有關的論文，例如動物實驗或臨床研究報告，只有在與人類疾病明確直接相關時才會被考慮。商業(yè)產品的評估在出版方面具有較低的優(yōu)先級，除非它們是新穎的或代表了技術突破。涉及藥物和天然產物影響的研究以及涉及各種疾病的氧化還原狀態(tài)的研究不屬于該期刊的范圍。還將考慮開發(fā)和評估適用于診斷臨床化學和實驗室醫(yī)學的新型分析方法，包括即時檢測，以及實驗室管理和信息學主題。專注于新興診斷技術和（大）數(shù)據(jù)分析程序的研究，包括數(shù)字化、移動醫(yī)療和應用于實驗室醫(yī)學的人工智能，也引起了人們的興趣。

Clinica Chimica Acta創(chuàng)刊于1956年，由Elsevier出版商出版，收稿方向涵蓋醫(yī)學 - 醫(yī)學實驗技術全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約3.0個月 約5.2周，影響因子指數(shù)3.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。